$41.78 -0.67 (-1.58%)
2/10/2012 4:00 PM

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

CAPS Rating: 3 out of 5

A biopharmaceutical company building an oncology business by developing and commercializing innovative therapies that target the molecular mechanisms implicated in cancer.

Featured Broker Partners


Advertisement